Carolyn is a health care technology executive with over 20 years of leadership experience in driving the transition from fee-for-service to value-based care.

Jeremy is an epidemiologist and computer scientist with nearly 25 years of experience in the science and technology of big data.

Sebastian is a physician and pharmacoepidemiologist with 25 years of experience in analyzing health care databases.

Lowell is the Chief Legal and Regulatory Officer of Aetion. Previously, Lowell served in several senior leadership roles at the U.S. FDA, most recently as the Principal Associate Commissioner for Policy.

Lori is an attorney with broad experience advising corporate clients in intellectual property, privacy, data security, corporate governance, and risk management.

John brings to Aetion decades of experience leading technology teams, most recently as the first CTO of Oden Technologies, a New York-based manufacturing analytics company.

Over her 20+ years in health care transformation, Liz has tackled numerous and varied go-to-market challenges across many high-growth, high-tech firms.

Richard is Chief Growth Officer to Aetion and has led business development for several health care technology companies serving the life sciences industry.

TC is Chief Financial Officer to Aetion, and his industry and corporate finance experience spans over 25 years in numerous industries. 

Julie is Senior Vice President of Scientific Engagement and Delivery at Aetion and has 17 years of experience at Pfizer working to improve overall R&D productivity.

David is Chief People Officer to Aetion and has nearly 20 years of experience building and leading human resources teams across public and private companies.

With more than a 20-year tenure investing in young and emerging healthcare technology companies, Bill Geary serves on boards of industry-leading companies, working closely with founders and management.

Mohamad Makhzoumi is a general partner at NEA and heads the firm’s Healthcare Services & Healthcare IT investment practice.

Dr. Scott Gottlieb is a Special Partner on the NEA healthcare investment team; he was a Venture Partner at NEA from 2007 to 2017 until being appointed the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), where he served from 2017 to 2019.

Cathy Polinsky is the Chief Technology Officer at Stitch Fix. In her role as CTO, Cathy has had responsibility over Engineering, IT, Product, User Experience, and Security functions. She started in 2016 and helped take the company public in 2017.

Oliver is a partner at Lakestar Capital, based in Zurich, Switzerland. He was part of the founding Lakestar team and in 2017 was featured in the Forbes 30 Under 30 list.

Adair is a principal at Greenspring Associates and is responsible for sourcing and due diligence efforts on fund, direct, and secondary opportunities. He is also involved in Greenspring Associates’ Portfolio Impact Program.

Arvind co-leads EDBI’s investment activities in the U.S. across various sectors—enterprise SaaS, financial markets tech, health tech, and agrifood.‍

Shumeet Banerji is founder and partner of Condorcet, LP, an investment and advisory firm. In 2013, Shumeet retired from Booz & Company Inc., having served as its founding chief executive officer.

Mohit Misra, M.D., is a physician, trained health economist, and ex-strategy consultant with over 15 years of experience in working with health care systems and life science companies in the U.S., Europe, and Asia.

Kavita Patel, M.D., joined NEA in 2017 as a venture partner on the health care team. In addition to her role at NEA, Kavita is a practicing primary care physician at Johns Hopkins Medicine and a fellow at the Brookings Institution.

Jonathan is the senior independent non-executive director of HSBC Holdings plc, chairman of HSBC Bank plc, and chairman of HSBC Holdings’ Group Audit Committee. He also sits on the Group Risk Committee.